Crosswinds Holdings Inc Share Price Toronto S.E.
Equities
CA2276961018
Biotechnology & Medical Research
Sales 2021 | - | Sales 2022 | - | Capitalization | 2.74Cr 3.72Cr 227.83Cr |
---|---|---|---|---|---|
Net income 2021 | -40L -54.44L -33Cr | Net income 2022 | -20L -27.22L -17Cr | EV / Sales 2021 | - |
Net cash position 2021 | 2.23 3.03 185.53 | Net cash position 2022 | 0.02 0.02 1.5 | EV / Sales 2022 | - |
P/E ratio 2021 |
-17.8
x | P/E ratio 2022 |
-9.17
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 60.21% |
1st Jan change | Capi. | |
---|---|---|
+33.63% | 5.08TCr | |
-0.09% | 4.28TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.95TCr | |
+11.18% | 2.61TCr | |
-21.95% | 1.91TCr | |
+8.61% | 1.31TCr | |
+28.31% | 1.22TCr | |
+24.73% | 1.21TCr |